Skip to content
Forest Global Training Partners
Home Services AI Governance AI Navigators Contact Us
AI Navigators AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Use Cases
  3. Tempus Receives U.S. FDA 510(k) Clearance for Tempus…

AI Use Cases June 26, 2024 · morningstar.com

Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm ...

Morningstar ... that uses AI to help identify patients who may be at increased risk of atrial fibrillation/flutter (AF). This is the first FDA clearance for an AF …

Read the original at morningstar.com ↗

Topics
Healthcare
Mentions
FDAUnited States
Tags
AI Use Case
Tracked via
Google Alert “that uses AI to”

Related articles

  • Personalis 13D Filing Shows Tempus AI Reported A 15.1% Stake In The Co As Of July 3, 2024 AI Use Cases · Jul 04, 2024
  • 3 Under-the-Radar IPO Stocks to Buy Before They Double | Investor Place AI Use Cases · Jul 16, 2024
  • 7 Growth Stocks That Can Create Millionaires by 2030 - Investor Place AI Use Cases · Jul 27, 2024
  • 7 New Growth Stock Listings That Can Be Long-Term Wealth Creators | Investor Place AI Use Cases · Aug 03, 2024
  • icometrix'sAI-driven MRI solution, icobrain aria receives US FDA clearance for safer ... AI Risks · Nov 16, 2024
  • 3 AI-in-Healthcare Stocks to Buy for Outsized Returns | Investor Place AI Use Cases · Jul 30, 2024

Shares players with

  • Personalis 13D Filing Shows Tempus AI Reported A 15.1% Stake In The Co As Of July 3, 2024
  • United States: What's Special About AI Risks And Remedies In Health Care? - Mondaq
  • FDA unveils long-awaited guidance on AI use to support drug and biologic development
  • AIDrug Development: FDA Releases Draft Guidance - Healthcare - United States
  • Without FDA Regulation,AITech in Healthcare Poses Dire Risksto Patients - Public Citizen
  • FDA Flags Cyber, AI Risks in Autonomous Medical Robots - BankInfoSecurity

AI Navigators is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact